Trending

patent litigation

Novartis secures initial block on Gilenya generics in US

Novartis secures initial block on Gilenya generics in US

Novartis has won a temporary reprieve from generic competition to its big-selling oral multiple sclerosis therapy Gilenya in

X

Novartis secures initial block on Gilenya generics in US

https://pharmaphorum.com/news/novartis-secures-initial-block-on-gilenya-generics-in-us/

EU Pharmaceutical Law Forum

DIG DEEPER INTO CUTTING EDGE TOPICS

X

EU Pharmaceutical Law Forum

https://pharmaphorum.com/events/eu-pharmaceutical-law-forum/

SMi’s release speaker interview Anita Burrell, speaker at Biosimilars USA

SMi’s release speaker interview Anita Burrell, speaker at Biosimilars USA

Biosimilars USA conference information

X

SMi’s release speaker interview Anita Burrell, speaker at Biosimilars USA

https://pharmaphorum.com/partner-content/smis-release-speaker-interview-anita-burrell-speaker-at-biosimilars-usa/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com